GBS Flashcards

1
Q

Guillain-Barré Syndrome is an acute, ___-mediated, inflammatory, demyelinating disorder with potential for chronic implications. The __ system attacks __ cells in PNS. Syndrome has multiple variant forms, the most common is ___ (ADIP). Also GBS is the most common type of __ __ __. Sensory, autonomic, and __ abnormalities may occur, but GBS is characterized by rapidly progressive ___, SYMMETRICAL motor weakness AND __ reflexes.

A

1) immune
2) immune system
3) Schwann cells
4) Acute Demyelinating Inflammatory Polyneuropathy
5) Acute paralytic neuropathy
6) brainstem
7) ascending
8) diminished

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

GBS peaks in frequency in young adults AND ____ decades. Incidence rates ___ with age (20% for every 10 year age increase), and is highest >__ years. Infections are associated w/ a ___ relationship and incidence is higher in the ___ gender.

A

1) 5-8th decades (40s-70s)
2) increase
3) >60 y/o
4) seasonal
5) male

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The triggering cause can be __ but more than 1/2 of cases occur after a bacterial or viral infection. ___ is found in undercooked food, esp. poultry. More than 1/2 of pt have a PMHx of URI or GI viral infection w/in the last month (4 wks). Other viral etiologies in __ virus, Epstein-Barr virus, and ____.
Other connections include __ disease, allergic response, post-trauma (surgery, post-natal), and __ which are VERY rare.

A

1) idiopathic
2) Campylobacteriosis
3) Zika virus
4) COVID-19
5) autoimmune disease
6) vaccinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Progression of S&S occurs from __ hours to __ days before plateau is reached. “__” (plateau) phase is __ wks then recovery occurs __ → __. Cardinal S&S include __ __, __ motor weakness with progression distal → proximal & __ weakness before __ weakness, and __reflexia

A

1&2) 12 hours to 28 days (rapid progression)
3) nadir
4) 2-4 weeks (days to 1 month)
5&6) proximally → distally
9&10) rapidly progressive, symmetrical
11) leg → arm weakness
12) hypo or areflexia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CN involvement is common, with CN __ most frequently involved. This CN’s involvement manifest as bilateral ___ weakness. Other CNs involved that manifest double vision are CNs __, __, & __. Dysphagia and laryngeal paralysis also can occur d/t CN __ and __ involvement.

A

1) Facial N (CN 7)
2) Facial
3-5) CN 3, 4, & 6 (oculomotor, trochlear, abducens Ns)
6&7) CN 9 & 10 (glossopharyngeal & vagus Ns)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Another common S&S is BRUTAL ___ or __ pain. Autonomic dysfunction can cause orthostatic hypotension (BP fluctuation), __cardia, and arrhythmias. Respiratory difficulties can occur but are not common. Sensory paresthesias and hyperesthesia can occur but will be seen much __ than motor impairments. __/__ ctrl remain intact.

A

1&2) neuropathic or msk pain
3) tachycardia
4) much LATER than motor
5&6) Bowel/Bladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NINDS dx criteria for GBS required what S&S for dx? (2)

A

1) Progressibe, symmetrical weakness of legs initially and arms (from mild weakness, to total paralysis)
2) Areflexia or Hyporeflexia in affected limbs
our cardinal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Components used to dx GBS include clinical exam, MRI which shows ___ of spinal N roots, NCVs (N conduction block, decr. amplitude or absent distal motor AP, decr. CV, incr. latency), and CSF exam showing ___ elevation by the 2nd week.

A

1) thickening/swelling of spinal N roots
2) protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

5 Supportive features part of NINDS criteria for GBS.
these are not required for dx, but support dx

A

1) Progression of symptoms <4 weeks (reach nadir in <4 wks)
2) Symmetry
3) Mild sensory symptoms or signs
4) Cranial nerve involvement, especially bilateral facial nerve weakness
5) Recovery starting 2-4 wks after nadir STARTS
6) Autonomic dysfunction
7) Pain
8) No fever at the onset
9) Elevated protein in CSF
10) Electrodiagnostic abnormalities consistent with GBS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

According to NINDS, these 5 features make GBS dx DOUBTFUL

A

1) Sensory loss > motor loss
2) asymmetry of weakness
3) Bowel and bladder dysfunction (at onset or severe/persistent)
4) Severe pulmonary dysfunction with little/no limb weakness at onset
5) Fever at onset (infection should be long gone by the time GBS presents)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

3 other variants of GBS besides AIDP are __, __, & __. __ presents with ophthalmoplegia, ataxia, & arreflexia. ___ (AMAN) and ___ (AMSAN) have axonal involvement & will be more severe in presentation. AMAN presents w/ muscle weakness, occasionally preserved ___, & sensory is SPARED. AMSAN impacts both __ and ___ nerves.

A

1-3) Miller-Fisher Syndrome, AMAN, & AMSAN
4) Miller-Fisher Syndrome
5) Acute Motor Axonal Neuropathy
6) Acute Motor-Sensory Axonal Neuropathy
7) DTRs
8&9) motor and sensory Ns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The earlier tx starts, the better! There is NO cure for GBS. Primary management goal is ___ __ __. Intravenous Immunoglobin (IVIg) uses plasma products made of __ extracted from blood and administers blood products to boost ___ production, blocking __ and antibody binding. IVIg shows benefits for more than 1/2 of pts w/ GBS. It can ___further myelin loss and axonal loss, also can aid in sustained remission.

A

1) Control Inflammatory response
2) antibodies
3) antigen
4) macrophage
5) PREVENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Plasma Exchange (__) removes blood plasma, separates it into plasma and cells, and transfuses __ back into bloodstream. Tx is 5 exchanges over 2 wks. This medical tx ___ N damage and shows faster clinical improvement. What pt population is this tx recommended for (be specific)?

A

1) Plasmapheresis
2) cells
3) reduced
4) Pts who CANNOT walk 10 M w/out ast.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acute phase of GBS is the rapid progression of S&S, within __ week(s) 50% of impairment shows and pts reach “nadir” within __ weeks. Pts are usually in hospital. Plateau phase can last from ___ up to ___. PT will be in the recovery phase where most pts regain ___ 2-4 wks after “nadir”. However, __ impairments and __ can persist for years.

A

1) 1 week
2) 2-4 weeks
3&4) days up to 1 month
5) strength
6) sensory
7) fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Potential complications includes resp. issues, pneumonia, prolonged hosp./immobility complications, and relapses. Name 2 more potential complications.

A

1) autonomic instability
2) pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most pts recover the ability to ___ within 6 months. Lingering S&S that may be difficult to manage involve mod/severe __, persistent __, and motor deficits like __ __. GBS mortality rate is ___. Total recovery time can take up to ____.

A

1) ambulate
2) pain
3) fatigue
4) foot drop (or paresthesia)
5) LOW
6) up to 2 years

16
Q

NEGATIVE prognostic indicators include: ___ age at onset, rapid onset (<7 days) ___ admission, hx of ___ illness prior to onset, and an avg distal motor response amplitude reduction to ____ of normal. Name 1 more (-) Prognostic indicator.

A

1) >60 y/o
2) BEFORE
3) GI (presence of diarrhea)
4) <20% of normal
5) Need for ventilatory support

17
Q

T/F: More than 1/2 of pts w/ GBS will require ventilatory support.

A

False, 1/3 of pts will need it though!

18
Q

What is the 2 measures are part of the International GBS Outcome Scale (IGOS) to estimate prognosis? Which one evaluates a pt’s risk of developing reps. failure in 1st week of admission? What 3 components does the measure assess to evaluate the risk?

A

1) Erasmus GBS Resp. Insufficiency Score (EGRIS) and Erasmus GBS Outcome Score (EGOS)
2) EGRIS
3) days b/w onset of weakness and hosp. admission, facial/bulbar weakness at admission, and UE/LE strength at admission

19
Q

EGOS estimates pts ability to ___ at __ months and can be used at 1 AND 2 weeks after admission. At week 1, mEGOS assesses ___ at day 7 of admission.
At week 2, the EGOS assesses GBS __ score after hosp. admission. What 2 components are assessed at week 1 AND week 2?

A

1&2) ambulate at 6 mo.
3) UE/LE strength
4) GBS disability score
5) age at onset & preceding diarrhea in the last 4 weeks

20
Q

There are 2 GBS Specific OMs. Which one is a 7-pt scale of global disability with 0 = healthy and 6 = death?

A

GBS Disability Scale

21
Q

Overall Disability Sum Score (ODSS) scores __ tasks on range of 0 (healthy) to 12 (severe disability). It can be scored during the __ __ or by the __. ODSS has a SIGNIFICANT association w/ pt’s ___ of clinical condition.

A

1) functional UE/LE
2&3) pt interview or by the individual
4) own perception

22
Q

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) presents similar to GBS but takes a chronic course. CIDP has gradual onset of S&S over the course of ___ weeks before any signs of plateau. S&S are motor AND sensory and can be symmetric or __. ___ are common, as CIDP does NOT improve after plateau. Onion bulb changes occur with CIDP as well. What med does CIDP respond to?

A

1) >8 weeks of S&S progression
2) asymmetric
3) Relapses
4) glucocorticoids